Reference Type:  Journal Article
Record Number: 1060
Author: Arbizu, J., Prieto, E., Martínez-Lage, P., Martí-Climent, J. M., García-Granero, M., Lamet, I., Pastor, P., Riverol, M., Gómez-Isla, M. T., Peñuelas, I., Richter, J. A. and Weiner, M. W.
Year: 2013
Title: Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia
Journal: European Journal of Nuclear Medicine and Molecular Imaging
Volume: 40
Issue: 9
Pages: 1394-1405
Short Title: Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia
ISSN: 16197070 (ISSN)
DOI: 10.1007/s00259-013-2458-z
Keywords: Alzheimer's disease
Dementia
FDG
Mild cognitive impairment
PET
Prediction
apolipoprotein E4
fluorodeoxyglucose f 18
aged
Alzheimer disease
area under the curve
article
brain mapping
brain metabolism
clinical article
controlled study
diagnostic accuracy
diagnostic test accuracy study
educational status
female
genotype
human
male
Mini Mental State Examination
neuroimaging
positron emission tomography
posterior cingulate
predictive value
principal component analysis
probability
sensitivity and specificity
temporal lobe
validation study
Aged, 80 and over
Brain
Case-Control Studies
Data Interpretation, Statistical
Fluorodeoxyglucose F18
Humans
Middle Aged
Models, Statistical
Positron-Emission Tomography
Predictive Value of Tests
Radiopharmaceuticals
Abstract: Purpose: To introduce, evaluate and validate a voxel-based analysis method of 18F-FDG PET imaging for determining the probability of Alzheimer's disease (AD) in a particular individual. Methods: The subject groups for model derivation comprised 80 healthy subjects (HS), 36 patients with mild cognitive impairment (MCI) who converted to AD dementia within 18 months, 85 non-converter MCI patients who did not convert within 24 months, and 67 AD dementia patients with baseline FDG PET scan were recruited from the AD Neuroimaging Initiative (ADNI) database. Additionally, baseline FDG PET scans from 20 HS, 27 MCI and 21 AD dementia patients from our institutional cohort were included for model validation. The analysis technique was designed on the basis of the AD-related hypometabolic convergence index adapted for our laboratory-specific context (AD-PET index), and combined in a multivariable model with age and gender for AD dementia detection (AD score). A logistic regression analysis of different cortical PET indexes and clinical variables was applied to search for relevant predictive factors to include in the multivariable model for the prediction of MCI conversion to AD dementia (AD-Conv score). The resultant scores were stratified into sixtiles for probabilistic diagnosis. Results: The area under the receiver operating characteristic curve (AUC) for the AD score detecting AD dementia in the ADNI database was 0.879, and the observed probability of AD dementia in the six defined groups ranged from 8 % to 100 % in a monotonic trend. For predicting MCI conversion to AD dementia, only the posterior cingulate index, Mini-Mental State Examination (MMSE) score and apolipoprotein E4 genotype (ApoE4) exhibited significant independent effects in the univariable and multivariable models. When only the latter two clinical variables were included in the model, the AUC was 0.742 (95 % CI 0.646 - 0.838), but this increased to 0.804 (95 % CI 0.714 - 0.894, bootstrap p = 0.027) with the addition of the posterior cingulate index (AD-Conv score). Baseline clinical diagnosis of MCI showed 29.7 % of converters after 18 months. The observed probability of conversion in relation to baseline AD-Conv score was 75 % in the high probability group (sixtile 6), 34 % in the medium probability group (merged sixtiles 4 and 5), 20 % in the low probability group (sixtile 3) and 7.5 % in the very low probability group (merged sixtiles 1 and 2). In the validation population, the AD score reached an AUC of 0.948 (95 % CI 0.625 - 0.969) and the AD-Conv score reached 0.968 (95 % CI 0.908 - 1.000), with AD patients and MCI converters included in the highest probability categories. Conclusion: Posterior cingulate hypometabolism, when combined in a multivariable model with age and gender as well as MMSE score and ApoE4 data, improved the determination of the likelihood of patients with MCI converting to AD dementia compared with clinical variables alone. The probabilistic model described here provides a new tool that may aid in the clinical diagnosis of AD and MCI conversion. © 2013 Springer-Verlag Berlin Heidelberg.
Notes: Cited By (since 1996):1
Export Date: 28 May 2014
Source: Scopus
CODEN: EJNMA
PubMed ID: 23715905
Language of Original Document: English
Correspondence Address: Arbizu, J.; Department of Nuclear Medicine, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008 Pamplona, Spain; email: jarbizu@unav.es
Chemicals/CAS: fluorodeoxyglucose f 18, 63503-12-8
Funding Details: U01 AG024904, NIH, National Institutes of Health
Funding Details: P30AG010129, NIH, National Institutes of Health
Funding Details: K01 AG030514, NIH, National Institutes of Health
References: Dubois, B., Feldman, H.H., Jacova, C., Cummings, J.L., Dekosky, S.T., Barberger-Gateau, P., Revising the definition of Alzheimer's disease: A new lexicon (2010) Lancet Neurol, 9, pp. 1118-1127. , 20934914 10.1016/S1474-4422(10)70223-4; McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, Jr.C.R., Kawas, C.H., The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) Alzheimers Dement, 7, pp. 263-269. , 21514250 10.1016/j.jalz.2011.03.005; Albert, M.S., Dekosky, S.T., Dickson, D., Dubois, B., Feldman, H.H., Fox, N.C., The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) Alzheimer Dement., 7, pp. 270-279. , 10.1016/j.jalz.2011.03.008; Sperling, R.A., Johnson, K.A., Dementia: New criteria but no new treatments (2012) Lancet Neurol, 11, pp. 4-5. , 22172609 10.1016/S1474-4422(11)70272-1; Bohnen, N.I., Djang, D.S.W., Herholz, K., Anzai, Y., Minoshima, S., Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: A review of the recent literature (2012) J Nucl Med, 53, pp. 59-71. , 22173840 10.2967/jnumed.111.096578 1:CAS:528:DC%2BC38XitFCjurw%3D; Landau, S., Harvey, D., Madison, C., Reiman, E., Foster, N., Aisen, P., Comparing predictors of conversion and decline in mild cognitive impairment (2010) Neurology, 75, pp. 230-238. , 20592257 10.1212/WNL.0b013e3181e8e8b8; Minoshima, S., Frey, K.A., Koeppe, R.A., Foster, N.L., Kuhl, D.E., A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET (1995) J Nucl Med, 36, pp. 1238-1248. , 7790950 1:STN:280:DyaK2MzhtFSgtQ%3D%3D; Herholz, K., Salmon, E., Perani, D., Baron, J.C., Holthoff, V., Frolich, L., Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET (2002) Neuroimage, 17, pp. 302-316. , 12482085 10.1006/nimg.2002.1208 1:STN:280:DC%2BD38jhvFOhsQ%3D%3D; Landau, S.M., Harvey, D., Madison, C.M., Koeppe, R.A., Reiman, E.M., Foster, N.L., Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI (2011) Neurobiol Aging, 32, pp. 1207-1218. , 19660834 10.1016/j.neurobiolaging.2009.07.002; Chen, K., Ayutyanont, N., Langbaum, J.B., Langbaum, J., Fleisher, A.S., Reschke, C., Characterizing Alzheimer's disease using a hypometabolic convergence index (2011) Neuroimage, 56, pp. 52-60. , 21276856 10.1016/j.neuroimage.2011.01.049 1:CAS:528:DC%2BC3MXjvVOltro%3D; Shaffer, J.L., Petrella, J.R., Sheldon, F.C., Choudhury, K.R., Calhoun, V.D., Coleman, R.E., Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR Imaging, and PET biomarkers (2013) Radiology, 266, pp. 583-591. , 23232293 10.1148/radiol.12120010; Caroli, A., Prestia, A., Chen, K., Ayutyanont, N., Landau, S.M., Madison, C.M., Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: Head-to-head comparison (2012) J Nucl Med, 53, pp. 592-600. , 22343502 10.2967/jnumed.111.094946 1:CAS:528:DC%2BC38XmvFejs70%3D; Herholz, K., Westwood, S., Haense, C., Dunn, G., Evaluation of a calibrated 18F-FDG PET score as a biomarker for progression in Alzheimer Disease and mild cognitive impairment (2011) J Nucl Med, 52, pp. 1218-1226. , 21764801 10.2967/jnumed.111.090902; Cruchaga, C., Fernández-Seara, M.A., Seijo-Martínez, M., Samaranch, L., Lorenzo, E., Hinrichs, A., Cortical atrophy and language network reorganization associated with a novel progranulin mutation (2009) Cerebral Cortex, 19, pp. 1751-1760. , 19020205 10.1093/cercor/bhn202; McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease (1984) Neurology, 34, pp. 939-944. , 6610841 10.1212/WNL.34.7.939 1:STN:280:DyaL2c3ks1altQ%3D%3D; Petersen, R.C., Mild cognitive impairment as a diagnostic entity (2004) J Intern Med, 256, pp. 183-194. , 15324362 10.1111/j.1365-2796.2004.01388.x 1:STN:280: DC%2BD2cvhvFCkug%3D%3D; Wahlund, L., Barkhof, F., Fazekas, F., Bronge, L., Augustin, M., Sjögren, M., A new rating scale for age-related white matter changes applicable to MRI and CT (2001) Stroke, 32, pp. 1318-1322. , 11387493 10.1161/01.STR.32.6.1318 1:STN:280:DC%2BD3MzhsVerug%3D%3D; Pascual, B., Prieto, E., Arbizu, J., Marti-Climent, J., Olier, J., Masdeu, J.C., Brain glucose metabolism in vascular white matter disease with dementia: Differentiation from Alzheimer disease (2010) Stroke, 41, pp. 2889-2893. , 21051671 10.1161/STROKEAHA.110.591552; Friston, K.J., Holmes, A.P., Worsley, K.J., Poline, J., Frith, C.D., Frackowiak, R.S.J., Statistical parametric maps in functional imaging: A general linear approach (1994) Hum Brain Mapp, 2, pp. 189-210. , 10.1002/hbm.460020402; Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain (2002) Neuroimage, 15, pp. 273-289. , 11771995 10.1006/nimg.2001.0978 1:STN:280:DC%2BD38%2FltFCntw%3D%3D; Hosmer, D.W., Lemeshow, S., (2000) Applied Logistic Regression, pp. 91-142. , 2 Wiley New York 10.1002/0471722146; Fox, J., (2008) Applied Regression Analysis and Generalized Linear Models, pp. 587-606. , 2 Sage Thousand Oaks; Perrin, R.J., Fagan, A.M., Holtzman, D.M., Multimodal techniques for diagnosis and prognosis of Alzheimer's disease (2009) Nature, 461, pp. 916-922. , 19829371 10.1038/nature08538 1:CAS:528:DC%2BD1MXht1KntLvO; Weiner, M.W., Veitch, D.P., Aisen, P.S., Beckett, L.A., Cairns, N.J., Green, R.C., The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception (2012) Alzheimers Dement, 8, pp. 1-S68. , 22047634 10.1016/j.jalz.2011.09.172; Drzezga, A., Grimmer, T., Henriksen, G., Mühlau, M., Perneczky, R., Miederer, I., Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease (2009) Neurology, 72, pp. 1487-1494. , 19339712 10.1212/WNL.0b013e3181a2e8d0 1:CAS:528:DC%2BD1MXkslOjs74%3D; Pievani, M., Galluzzi, S., Thompson, P.M., Rasser, P.E., Bonetti, M., Frisoni, G.B., APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease (2011) Neuroimage, 55, pp. 909-919. , 21224004 10.1016/j.neuroimage.2010.12.081 1:CAS:528:DC%2BC3MXjs12jsL8%3D; Chen, K., Ayutyanont, N., Langbaum, J.B., Langbaum, J., Fleisher, A.S., Reschke, C., Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein e ε4 gene dose in cognitively normal adults: A cross-validation study using voxel-based multi-modal partial least squares (2012) Neuroimage, 60, pp. 2316-2322. , 22348880 10.1016/j.neuroimage.2012.02.005 1:CAS:528:DC%2BC38XltVyrtL0%3D; Reiman, E.M., Uecker, A., Caselli, R.J., Lewis, S., Bandy, D., De Leon, M.J., Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease (1998) Ann Neurol, 44, pp. 288-291. , 9708558 10.1002/ana.410440226 1:STN:280:DyaK1cznt1alsQ%3D%3D; Drzezga, A., Grimmer, T., Riemenschneider, M., Lautenschlager, N., Siebner, H., Alexopoulus, P., Prediction of individual clinical outcome in MCI by means of genetic assessment and 18F-FDG PET (2005) J Nucl Med, 46, pp. 1625-1632. , 16204712 1:CAS:528:DC%2BD28XitVGltrc%3D; Mosconi, L., Perani, D., Sorbi, S., Herholz, K., Nacmias, B., Holthoff, V., MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET (2004) Neurology, 63, pp. 2332-2340. , 15623696 10.1212/01.WNL.0000147469.18313.3B 1:STN:280: DC%2BD2cnkslWitw%3D%3D; Schuff, N., Woerner, N., Boreta, L., Kornfield, T., Shaw, L., Trojanowski, J., MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers (2009) Brain, 132, pp. 1067-1077. , 19251758 10.1093/brain/awp007 1:STN:280:DC%2BD1M3ns1Klug%3D%3D; Bouwman, F.H., Verwey, N.A., Klein, M., Kok, A., Blankenstein, M., Sluimer, J., New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population (2010) Dement Geriatr Cogn Disord, 30, pp. 1-7. , 20606438 10.1159/000315542 1:STN:280:DC%2BC3cfgtVyqsg%3D%3D; Schoonenboom, N.S.M., Van Der Flier, W.M., Blankenstein, M.A., Bouwman, F.H., Van Kamp, G.J., Barkhof, F., CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease (2008) Neurobiol Aging, 29, pp. 669-675. , 17208336 10.1016/j.neurobiolaging.2006.11.018 1:CAS:528: DC%2BD1cXktVKgu7s%3D; Minoshima, S., Giordani, B., Berent, S., Frey, K.A., Foster, N.L., Kuhl, D.E., Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease (1997) Ann Neurol, 42, pp. 85-94. , 9225689 10.1002/ana.410420114 1:STN:280:DyaK2szmvFajsw%3D%3D; Mosconi, L., Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD (2005) Eur J Nucl Med Mol Imaging, 32, pp. 486-510. , 15747152 10.1007/s00259-005-1762-7 1:CAS:528:DC%2BD2MXjtV2hs7o%3D; Jack, Jr.C.R., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade (2010) Lancet Neurol, 9, pp. 119-128. , 20083042 10.1016/S1474-4422(09)70299-6 1:CAS:528:DC%2BC3cXhtFeru74%3D; Pagani, M., Dessi, B., Morbelli, S., Brugnolo, A., Salmaso, D., Piccini, A., MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings (2010) Curr Alzheimer Res, 7, pp. 287-294. , 19939228 10.2174/156720510791162368 1:CAS:528:DC%2BC3cXmvFaisr4%3D; Drzezga, A., Lautenschlager, N., Siebner, H., Riemenschneider, M., Willoch, F., Minoshima, S., Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: A PET follow-up study (2003) Eur J Nucl Med Mol Imaging, 30, pp. 1104-1113. , 12764551 10.1007/s00259-003-1194-1; Yakushev, I., Schreckenberger, M., Müller, M.J., Schermuly, I., Cumming, P., Stoeter, P., Functional implications of hippocampal degeneration in early Alzheimer's disease: A combined DTI and PET study (2011) Eur J Nucl Med Mol Imaging, 38, pp. 2219-2227. , 21792570 10.1007/s00259-011-1882-1; Morbelli, S., Drzezga, A., Perneczky, R., Frisoni, G.B., Caroli, A., Van Berckel, B.N., Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project (2012) Neurobiol Aging, 33, pp. 2533-2550. , 22365486 10.1016/j.neurobiolaging.2012.01.005
URL: http://www.scopus.com/inward/record.url?eid=2-s2.0-84881670522&partnerID=40&md5=6c98e6bd8db42ac625ec60dcbec34831
Author Address: Department of Nuclear Medicine, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008 Pamplona, Spain
Department of Neurology, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008 Pamplona, Spain
Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Calle Irunlarrea 1, 31008 Pamplona, Spain
Center for Imaging of Neurodegenerative Diseases (CIND), San Francisco VA Medical Center, 4150 Clement Street (114M), San Francisco, CA 94121, United States
Fundación CITA-Alzheimer Fundazioa, Center for Research and Advanced Therapies Alzheimer, Parque Tecnológico de San Sebastián, Mikeletegi 71, bajo, 20009 San Sebastián, Spain
Neurology Department, Massachusetts General Hospital, WACC, 15 Parkman St, Boston, MA 02114, United States


